SCHEMBL28465739

SCHEMBL28465739

Cc1cc(F)ccc1-c1nc(S(C)(=O)=O)nc(Nc2c(F)cccc2F)c1C=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 3/20 0.36
CTSA P10619 3/20 0.33
BRD4 O60885 1/20 0.33
PTGS2 P35354 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
FABP1 P07148 1/20 0.32
SDHB P21912 1/20 0.31
CDK2 P24941 2/20 0.31
CDK9 P50750 2/20 0.31
CCNT1 O60563 1/20 0.31
CCNE1 P24864 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
ABL1 P00519 1/20 0.30
DHODH Q02127 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MITF O75030 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
STAT3 P40763 1/20 0.30
STAT1 P42224 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29594311 1.00 MAPK14 (0.36) MAPK14CTSABRD4PTGS2RXFP1
SCHEMBL28899979 0.89 MAPK14 (0.39) MAPK14CTSABRD4PTGS2RXFP1
SCHEMBL29593255 0.89 MAPK14 (0.39) MAPK14CTSABRD4PTGS2RXFP1
SCHEMBL27806131 0.85 MAPT (0.35) MAPK14PTGS2SDHBKDM4EMITF
SCHEMBL29593738 0.85 MAPT (0.35) MAPK14PTGS2SDHBKDM4EMITF
SCHEMBL1064841 0.83 HSP90AB1 (0.44) MAPK14CTSARXFP1HDAC9ABL1
SCHEMBL28461712 0.82 KCNH2 (0.37) MAPK14BRD4PTGS2CDK2ABL1
SCHEMBL29594254 0.82 KCNH2 (0.37) MAPK14BRD4PTGS2CDK2ABL1
SCHEMBL29593211 0.82 PTGS2 (0.37) MAPK14BRD4PTGS2RXFP1SDHB
SCHEMBL28464519 0.82 PTGS2 (0.37) MAPK14BRD4PTGS2RXFP1SDHB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114748622-A P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD 弗尔康医疗公司 2022-07-15 CN disclosed
CN-114732910-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-07-12 CN disclosed
CN-111601593-B P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-04-15 CN disclosed
CN-111601593-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2020-08-28 CN disclosed